Immunization with C5a Peptidase or Peptidase-Type III Polysaccharide Conjugate Vaccines Enhances Clearance of Group B Streptococci from Lungs of Infected Mice
Group B streptococci (GBS) are among the most common causes of life-threatening neonatal infections. Vaccine development since the late 1970s has focused on the capsular polysaccharides, but a safe, effective product is still not available. Our quest for a vaccine turned to the streptococcal C5a pep...
保存先:
| 出版年: | Infect Immun |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2002
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130386/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12379721/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.11.6409-6415.2002 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
